BibTex RIS Cite

Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients.

Year 2011, Volume: 8 Issue: 3, 214 - 217, 01.09.2011

Abstract

References

  • Houben E, Nguyen L, Pieters J. "Interaction of pathogenic mycobacteria with the host immune system". Curr Opin Microbiology 2006;9(1):76–85.
  • Singh R, Manjunatha U, Helena I, Bushoff M, Hwan-Ha Y. PA-824 kills non replicating M. tuberculosis by intracel- lular NO release. Science 2008;322(5906);1392-5.
  • Nathan C. Inducible nitric oxide synthase: what differ- ence does it make? Journal of Clinical Investigation 1997; 100:2417-23.
  • Ramanujam M.D. Free radicals and antioxidants–current status. www.meclindia.net/article/anitoxidantsasp; 2004
  • Plit Ml, Theron AS, Fickl H, Van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentration of vitamin C; Vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculo- sis. Intern J Tuberc lung Dis 1998;2(7):590-6.
  • Chandara I, Lalitha VK, Silambu C, et al. Serum neop- terin levels in HIV–infected patients with and without tu- berculosis. Indian J Med Research 2005;121:220-5.
  • Turgut T, Akbulut H, Devesi F, Kacar C, Muz MH. Serum interleukin-2- and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J Experimental Med 2006;209(4):321-8
  • Miyazawa T. Determination of phopholipid hydroperox- ides in human blood plasma by a chemiluminescence HPLC assay. Free Radical Biol Med 1989;7:209-17.
  • Varshney R, Kale RK. Effect of calmodulin antagonist on radiation-induced lipid peroxidation in microsomes. Int J Rad Boil 1990;58:733-43.
  • Wanchu A, Khullar M, Bhatnagar A, Sud A, Bambery P, Singh S. Pentoxiphylline Reduces Nitric Oxide Production among Patients with HIV Infection. Immunol Lett 2000; 74:121–5.
  • Smith D. Zouridakis E. Mariani M. Fredericks S. Cole D. Kaski J. Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae sero- positivity. Am Heart J 2003;146(1): 69-74.
  • Harma M, Harma M. Erel O. Oxidative stress in women with pre-eclampsia Am J Obstest Gynaecol 2005;192: 656-7.
  • Benzie IE, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power (the FRAP as- say). Ann Biochem 1996;239:70-6.
  • Suttle NF. The Veterinary Record 1986; 519-22.
  • Beutler E, Dunn O and Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;65:882-8.
  • Sinha KA. Colorimetry assay of catalase. Analytical Biochemistry 1972;47:389-94.
  • Nwanjo H. U. Free Radicals Scavenging Potential of the aqueous extract of Viscum Album (Mistletoe) leaves in diabetic wistar rats hepatocytes. The Internet Journal of Nutrition and Wellness. 2007; (3) 2.
  • Wiid I. Seaman T. Hoal Eg. Benade AJ. Van Helden PD. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy. IUBMB Life 2004;56(2): 101-6.
  • Akiibinu MO, Arinola OG, Ogunyemi EO. Plasma neopterin and peroxide levels in pulmonary tuberculosis patients on chemotherapy with or without micronutrient supplemen- tation. Pakistan J Med Sci 2009;25(3):380-5.
  • Kwiatsowska S. Piasecka G. Zieba M. Piotrowski W. Nowak D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuber- culosis. Respir Med 1999;93(4):272-6.
  • deRojas-Walker T, Tamir SJ, H Wishnock J, Tennaaum SR. Nitric oxide inducxes oxidative damage in addition to de- amination in macrophage DNA. Chem Research Toxicol 1995;8:473-7.
  • Apple FS, Wu AH, Mair J, et al. Future Biomarkers for de- tection of Ischemia and risk stractification in acute coro- nary syndrome. Clin Chemistry 2005;51:810-24.
  • Akiibinu MO, Arinola OG, Ogunlewe JO, Onih EA. Non enzymatic antioxidants and Nutritional profile in newly diagnosed pulmonary tuberculosis patients in Nigeria. African J Biomed Research 2007;10:223-8.
  • Madebo T, Lindtjİrn B, Aukrust P, Rolf K Berge. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Clin Nutrition. 2003;78(1):117-22.
  • Arinola OG, Akiibinu MO. Influence of Mycobacterium tu- berculosis infection on the serum levels of antioxidant vitamins and trace elements. The tropical Journal of Health Sciences 2008;15(2):1-4.
  • Sasaki Y, Yamagishi F, Yagi T, Mizutani F, A case of pul- monary tuberculosis with pan-cytopenia accompanied to bone marrow gelatinous transformation. Kekkaku 1999; 74 (4):361-4.
  • Aily D.C., Camargo S.S., Paro H.S., et al. Systematic my- cobacteriosis in AIDS patients as determined by blood cultures on biphasic medium. Rev Argent Microbiol 1999; 31:53-7.
  • Schon T, Gebre N, Sundqvist T, Aderaye G, Britton S. Effects of HIV co-infection and chemotherapy on the uri- nary levels of nitric oxide metabolites in patients with pulmonary tuberculosis. Scand J Infect Dis 1999; 31:123–6.
  • Gaston B, Drazen JM, Loscalzo J, and Stanler JS. The bi- ology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149:538-51.
  • Kaufmann S. "Protection against tuberculosis: cytokines, T cells, and macrophages". Ann Rheum Dis 2002;61:Suppl 2:ii54-8.
  • Joshi AS, Li XC, Nimrod AC, ElSohly HN, Walker LA, Clark AM. Dihydrochalcones from Piper longicaudatum. Planta Medica 2001;67:186–8.
  • Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarthy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Letters 1993;334:170-4.
  • Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein ty- rosine in human atheroscerosis detected by immunohisto- chemistry. Biological Chemistry; Hoppe Seyler 1994;375: 81-8.
  • Ferdinandy P, Schulz R. Nitric oxide, superoxide, and per- oxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British J Pharmacol 2003;138:532–43.

Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients.

Year 2011, Volume: 8 Issue: 3, 214 - 217, 01.09.2011

Abstract

-

References

  • Houben E, Nguyen L, Pieters J. "Interaction of pathogenic mycobacteria with the host immune system". Curr Opin Microbiology 2006;9(1):76–85.
  • Singh R, Manjunatha U, Helena I, Bushoff M, Hwan-Ha Y. PA-824 kills non replicating M. tuberculosis by intracel- lular NO release. Science 2008;322(5906);1392-5.
  • Nathan C. Inducible nitric oxide synthase: what differ- ence does it make? Journal of Clinical Investigation 1997; 100:2417-23.
  • Ramanujam M.D. Free radicals and antioxidants–current status. www.meclindia.net/article/anitoxidantsasp; 2004
  • Plit Ml, Theron AS, Fickl H, Van Rensburg CE, Pendel S, Anderson R. Influence of antimicrobial chemotherapy and smoking status on the plasma concentration of vitamin C; Vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculo- sis. Intern J Tuberc lung Dis 1998;2(7):590-6.
  • Chandara I, Lalitha VK, Silambu C, et al. Serum neop- terin levels in HIV–infected patients with and without tu- berculosis. Indian J Med Research 2005;121:220-5.
  • Turgut T, Akbulut H, Devesi F, Kacar C, Muz MH. Serum interleukin-2- and neopterin levels as useful markers for treatment of active pulmonary tuberculosis. Tohoku J Experimental Med 2006;209(4):321-8
  • Miyazawa T. Determination of phopholipid hydroperox- ides in human blood plasma by a chemiluminescence HPLC assay. Free Radical Biol Med 1989;7:209-17.
  • Varshney R, Kale RK. Effect of calmodulin antagonist on radiation-induced lipid peroxidation in microsomes. Int J Rad Boil 1990;58:733-43.
  • Wanchu A, Khullar M, Bhatnagar A, Sud A, Bambery P, Singh S. Pentoxiphylline Reduces Nitric Oxide Production among Patients with HIV Infection. Immunol Lett 2000; 74:121–5.
  • Smith D. Zouridakis E. Mariani M. Fredericks S. Cole D. Kaski J. Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae sero- positivity. Am Heart J 2003;146(1): 69-74.
  • Harma M, Harma M. Erel O. Oxidative stress in women with pre-eclampsia Am J Obstest Gynaecol 2005;192: 656-7.
  • Benzie IE, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power (the FRAP as- say). Ann Biochem 1996;239:70-6.
  • Suttle NF. The Veterinary Record 1986; 519-22.
  • Beutler E, Dunn O and Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;65:882-8.
  • Sinha KA. Colorimetry assay of catalase. Analytical Biochemistry 1972;47:389-94.
  • Nwanjo H. U. Free Radicals Scavenging Potential of the aqueous extract of Viscum Album (Mistletoe) leaves in diabetic wistar rats hepatocytes. The Internet Journal of Nutrition and Wellness. 2007; (3) 2.
  • Wiid I. Seaman T. Hoal Eg. Benade AJ. Van Helden PD. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy. IUBMB Life 2004;56(2): 101-6.
  • Akiibinu MO, Arinola OG, Ogunyemi EO. Plasma neopterin and peroxide levels in pulmonary tuberculosis patients on chemotherapy with or without micronutrient supplemen- tation. Pakistan J Med Sci 2009;25(3):380-5.
  • Kwiatsowska S. Piasecka G. Zieba M. Piotrowski W. Nowak D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuber- culosis. Respir Med 1999;93(4):272-6.
  • deRojas-Walker T, Tamir SJ, H Wishnock J, Tennaaum SR. Nitric oxide inducxes oxidative damage in addition to de- amination in macrophage DNA. Chem Research Toxicol 1995;8:473-7.
  • Apple FS, Wu AH, Mair J, et al. Future Biomarkers for de- tection of Ischemia and risk stractification in acute coro- nary syndrome. Clin Chemistry 2005;51:810-24.
  • Akiibinu MO, Arinola OG, Ogunlewe JO, Onih EA. Non enzymatic antioxidants and Nutritional profile in newly diagnosed pulmonary tuberculosis patients in Nigeria. African J Biomed Research 2007;10:223-8.
  • Madebo T, Lindtjİrn B, Aukrust P, Rolf K Berge. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am J Clin Nutrition. 2003;78(1):117-22.
  • Arinola OG, Akiibinu MO. Influence of Mycobacterium tu- berculosis infection on the serum levels of antioxidant vitamins and trace elements. The tropical Journal of Health Sciences 2008;15(2):1-4.
  • Sasaki Y, Yamagishi F, Yagi T, Mizutani F, A case of pul- monary tuberculosis with pan-cytopenia accompanied to bone marrow gelatinous transformation. Kekkaku 1999; 74 (4):361-4.
  • Aily D.C., Camargo S.S., Paro H.S., et al. Systematic my- cobacteriosis in AIDS patients as determined by blood cultures on biphasic medium. Rev Argent Microbiol 1999; 31:53-7.
  • Schon T, Gebre N, Sundqvist T, Aderaye G, Britton S. Effects of HIV co-infection and chemotherapy on the uri- nary levels of nitric oxide metabolites in patients with pulmonary tuberculosis. Scand J Infect Dis 1999; 31:123–6.
  • Gaston B, Drazen JM, Loscalzo J, and Stanler JS. The bi- ology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994;149:538-51.
  • Kaufmann S. "Protection against tuberculosis: cytokines, T cells, and macrophages". Ann Rheum Dis 2002;61:Suppl 2:ii54-8.
  • Joshi AS, Li XC, Nimrod AC, ElSohly HN, Walker LA, Clark AM. Dihydrochalcones from Piper longicaudatum. Planta Medica 2001;67:186–8.
  • Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarthy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Letters 1993;334:170-4.
  • Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein ty- rosine in human atheroscerosis detected by immunohisto- chemistry. Biological Chemistry; Hoppe Seyler 1994;375: 81-8.
  • Ferdinandy P, Schulz R. Nitric oxide, superoxide, and per- oxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British J Pharmacol 2003;138:532–43.
There are 34 citations in total.

Details

Primary Language English
Journal Section Original Articles
Authors

Moses Olayemi Akiibinu This is me

Ebenezer Olugbenga Ogunyemi This is me

Emmanuel Olusegun Shoyebo This is me

Publication Date September 1, 2011
Published in Issue Year 2011 Volume: 8 Issue: 3

Cite

APA Akiibinu, M. O., Ogunyemi, E. O., & Shoyebo, E. O. (2011). Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients. European Journal of General Medicine, 8(3), 214-217.
AMA Akiibinu MO, Ogunyemi EO, Shoyebo EO. Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients. European Journal of General Medicine. September 2011;8(3):214-217.
Chicago Akiibinu, Moses Olayemi, Ebenezer Olugbenga Ogunyemi, and Emmanuel Olusegun Shoyebo. “ Antioxidants and Neopterin in Nigerian Pulmonary Tuberculosis Patients”. European Journal of General Medicine 8, no. 3 (September 2011): 214-17.
EndNote Akiibinu MO, Ogunyemi EO, Shoyebo EO (September 1, 2011) Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients. European Journal of General Medicine 8 3 214–217.
IEEE M. O. Akiibinu, E. O. Ogunyemi, and E. O. Shoyebo, “ antioxidants and neopterin in Nigerian pulmonary tuberculosis patients”., European Journal of General Medicine, vol. 8, no. 3, pp. 214–217, 2011.
ISNAD Akiibinu, Moses Olayemi et al. “ Antioxidants and Neopterin in Nigerian Pulmonary Tuberculosis Patients”. European Journal of General Medicine 8/3 (September 2011), 214-217.
JAMA Akiibinu MO, Ogunyemi EO, Shoyebo EO. Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients. European Journal of General Medicine. 2011;8:214–217.
MLA Akiibinu, Moses Olayemi et al. “ Antioxidants and Neopterin in Nigerian Pulmonary Tuberculosis Patients”. European Journal of General Medicine, vol. 8, no. 3, 2011, pp. 214-7.
Vancouver Akiibinu MO, Ogunyemi EO, Shoyebo EO. Levels of oxidative metabolites, antioxidants and neopterin in Nigerian pulmonary tuberculosis patients. European Journal of General Medicine. 2011;8(3):214-7.